Last reviewed · How we verify
LongShengZhi capsule
LongShengZhi capsule is a Small molecule drug developed by Dongzhimen Hospital, Beijing. It is currently in Phase 1 development.
At a glance
| Generic name | LongShengZhi capsule |
|---|---|
| Sponsor | Dongzhimen Hospital, Beijing |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LongShengZhi capsule CI brief — competitive landscape report
- LongShengZhi capsule updates RSS · CI watch RSS
- Dongzhimen Hospital, Beijing portfolio CI
Frequently asked questions about LongShengZhi capsule
What is LongShengZhi capsule?
LongShengZhi capsule is a Small molecule drug developed by Dongzhimen Hospital, Beijing.
Who makes LongShengZhi capsule?
LongShengZhi capsule is developed by Dongzhimen Hospital, Beijing (see full Dongzhimen Hospital, Beijing pipeline at /company/dongzhimen-hospital-beijing).
What development phase is LongShengZhi capsule in?
LongShengZhi capsule is in Phase 1.
Related
- Manufacturer: Dongzhimen Hospital, Beijing — full pipeline
- Compare: LongShengZhi capsule vs similar drugs
- Pricing: LongShengZhi capsule cost, discount & access